STENTiT is proud to announce that it has been selected among the top 10 European companies to participate in one of the largest start-up competitions in tissue engineering and regenerative medicine across Europe, the TERMIS-EU BPC.
TERMIS is the world’s leading non-profit forum for academic and industrial developments within the fields of tissue engineering and regenerative medicine (TERM), bringing together leading academics, industry experts and young investigators. Through regular conferences, publications and other forms of communication and activities, TERMIS promotes education, research and commercialisation and serves as an international forum for discussing the challenges, applications and therapeutic benefits of TERM technologies.
